Completed PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT01739374

Efficacy and Safety of Reduced Pelvic Floor Mesh Implants

Phase 2-3 Study of Efficacy and Safety of Reduced Pelvic Floor Mesh Implants

Sponsor: Western Galilee Hospital-Nahariya

Conditions Complication of Surgical Procedure Post Operative Pain

Updated 5 times since 2017 Last updated: Jun 17, 2015 Started: May 31, 2013 Primary completion: May 31, 2014 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Complication of Surgical Procedure and Post Operative Pain, this trial is completed. The trial is conducted by Western Galilee Hospital-Nahariya and has accumulated 5 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Western Galilee Hospital-Nahariya

Data source: Western Galilee Hospital-Nahariya

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nahariya, Israel